Natural Capsules Limited has informed the Exchange about General Updates
NATCAPSUQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natural Capsules Limited has informed the stock exchanges that its material subsidiary, Natural Biogenex Private Limited, will not be proceeding with the allotment of shares under a Rights Issue. This decision was taken at the subsidiary's Board meeting held on January 3, 2026. The reason cited is non-subscription by the major shareholder, meaning the key investor did not participate in the rights offering. This follows an earlier intimation made by Natural Capsules Limited on September 30, 2025 regarding the rights issue plans. Natural Biogenex is classified as a 'Material Subsidiary' of Natural Capsules, meaning this development has direct relevance to the parent company's operations.
This is a negative development as the subsidiary has failed to raise capital through the planned rights issue. Shareholders should note that fundraising plans for the subsidiary have stalled, which could affect future growth or expansion plans of that business vertical. Near-term stock price reaction may be muted as the subsidiary-level impact is limited, but it signals internal capital-raising challenges.